Glenn Martin Sammis

Title: Glenn Martin Sammis: Innovator in Analyte Detection and Neurological Treatments

Introduction

Glenn Martin Sammis is a notable inventor based in Vancouver, Canada. He has made significant contributions to the fields of analyte detection and the treatment of neurological diseases. With a total of 2 patents, his work showcases innovative methods and compounds that address critical health issues.

Latest Patents

Sammis's latest patents include "Apparatus and methods for detecting and quantifying analytes" and "Tetrahydroprotoberbine compounds and uses thereof in the treatment of neurological, psychiatric and neurodegenerative diseases." The first patent focuses on methods for rapid detection and quantification of analytes, particularly opioids like fentanyl. This method utilizes an internal standard introduced into an unknown sample, which may involve a separation step before electrochemical detection. The second patent discusses Tetrahydroprotoberbine (THPB) compounds and their potential in treating various neurological conditions. It includes enantioselective processes for preparing these compounds, which are crucial for developing effective treatments.

Career Highlights

Throughout his career, Sammis has worked with esteemed institutions, including the University of British Columbia. His research has led to advancements in both analytical chemistry and pharmacology, making a lasting impact on these fields.

Collaborations

Sammis has collaborated with notable individuals such as James Jackson Miller and Anthony George Phillips. These partnerships have contributed to the development of his innovative patents and research.

Conclusion

Glenn Martin Sammis is a distinguished inventor whose work in analyte detection and neurological treatments has the potential to improve health outcomes significantly. His contributions reflect a commitment to innovation and excellence in research.